Literature DB >> 18335223

[Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis].

E Schmidt1, T Meyer-Ter-Vehn, D Zillikens, G Geerling.   

Abstract

Mucous membrane pemphigoid is a subepidermal blistering autoimmune disorder characterized by predominant involvement of mucous membranes and the presence of autoantibodies against proteins of the dermal-epidermal junction. Lesions most frequently develop in the oral cavity followed, in descending order of frequency, by conjunctiva, nasopharynx, the anogenital region, skin, larynx, and oesophagus. When the lesions are restricted to the conjunctiva, the term ocular pemphigoid may be applied. Cicatrization of the plica is considered a pathognomonic sign in early disease. Recurrent conjunctival inflammation results in subepithelial fibrosis, which leads to fornix shortening, symblepharon formation and subsequent trichiasis and entropion. Even in the absence of conjunctival inflammation, ankyloblepharon may occur. In end stage disease, limbal stem cell deficiency, tear deficiency, and lid malpositions may occur and result in a total keratinization of the ocular surface. The diagnosis is based on clinical findings and the detection of linear deposits of IgG and/or IgA and/or C3 at the dermal-epidermal junction by direct immunofluorescence microscopy of a perilesional biopsy. Autoantibodies (against type XVII and VII collagen, laminin 5 and 6, alpha6beta4 integrin, BP230) have been detected in patient serum. In the case of ocular involvement, preferential reactivity against beta4 integrin has been described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18335223     DOI: 10.1007/s00347-008-1699-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.174


  54 in total

1.  Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and laminin 5.

Authors:  Grace K Mulyowa; Gerold Jaeger; Cassian Sitaru; Eva-B Bröcker; Detlef Zillikens; Enno Schmidt
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

2.  Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.

Authors:  Vassiliki Bekou; Sybille Thoma-Uszynski; Olaf Wendler; Wolfgang Uter; Susanne Schwietzke; Thomas Hunziker; Christos C Zouboulis; Gerold Schuler; Lydia Sorokin; Michael Hertl
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

3.  Autoimmune phenomena in ocular cicatricial pemphigoid.

Authors:  B J Mondino; A N Ross; B S Rabin; S I Brown
Journal:  Am J Ophthalmol       Date:  1977-04       Impact factor: 5.258

4.  Anti-epiligrin cicatricial pemphigoid and relative risk for cancer.

Authors:  C A Egan; Z Lazarova; T N Darling; C Yee; T Coté; K B Yancey
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

5.  Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.

Authors:  N Oyama; J F Setterfield; A M Powell; Y Sakuma-Oyama; S Albert; B S Bhogal; R W Vaughan; F Kaneko; S J Challacombe; M M Black
Journal:  Br J Dermatol       Date:  2006-01       Impact factor: 9.302

6.  Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva.

Authors:  A Heiligenhaus; J E Dutt; C S Foster
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

7.  Mucous membrane pemphigoid and pseudopemphigoid.

Authors:  Jennifer E Thorne; Grant J Anhalt; Douglas A Jabs
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

8.  Glaucoma in patients with ocular cicatricial pemphigoid.

Authors:  J Tauber; S Melamed; C S Foster
Journal:  Ophthalmology       Date:  1989-01       Impact factor: 12.079

9.  Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.

Authors:  G Kirtschig; M P Marinkovich; R E Burgeson; K B Yancey
Journal:  J Invest Dermatol       Date:  1995-10       Impact factor: 8.551

10.  The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.

Authors:  Pablo Argüeso; Ann Tisdale; Ulla Mandel; Erik Letko; C Stephen Foster; Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

View more
  8 in total

1.  [Tumour of the conjunctiva with diffuse cicatrisation].

Authors:  H M Riederle; E Schmidt; M Eck; T Meyer-ter-Vehn; G Geerling
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

2.  [Treatment-refractory anti-laminin 332 mucous membrane pemphigoid. Remission following adjuvant immunoadsorption and rituximab].

Authors:  A Recke; I Shimanovich; P Steven; L Westermann; D Zillikens; E Schmidt
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

Review 3.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

Review 4.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

5.  Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency.

Authors:  Sophie X Deng; Vincent Borderie; Clara C Chan; Reza Dana; Francisco C Figueiredo; José A P Gomes; Graziella Pellegrini; Shigeto Shimmura; Friedrich E Kruse
Journal:  Cornea       Date:  2019-03       Impact factor: 2.651

6.  [Transplants from the hard palate: method for mucosal graft reconstruction of the upper eyelid].

Authors:  M Emesz; E M Krall; M Rasp; F M Bauer; G Grabner; E M Arlt
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

Review 7.  [Mucous membrane pemphigoid].

Authors:  M M Holtsche; D Zillikens; E Schmidt
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 8.  Limbal stem cell diseases.

Authors:  Clémence Bonnet; JoAnn S Roberts; Sophie X Deng
Journal:  Exp Eye Res       Date:  2021-02-08       Impact factor: 3.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.